Filing Scope and Business Context
The provided filing is Agrify Corporation’s Form 10-K for the fiscal year ended December 31, 2022, not a filing for RYTHM, Inc. The filing covers Agrify’s cultivation and extraction solutions for the cannabis and hemp industries, including vertical farming units, Agrify Insights software, extraction equipment, facility build-outs, and related services. The filing was signed November 27, 2023 and includes audited fiscal-year information for 2022 and 2021. The source does not provide a separate fourth-quarter presentation.
Key Financial Metrics
| Metric | 2022 | 2021 | Change |
|---|---|---|---|
| Revenue | $58.3 million | $59.9 million | Down 3% |
| Gross profit/(loss) | $(31.8) million | $5.2 million | Down $37.0 million |
| Gross margin | (54.6%) | 8.7% | Down 63.3 percentage points |
| Loss from operations | $(193.3) million | $(35.1) million | Higher loss by $158.3 million |
| Net loss attributable to Agrify | $(188.2) million | $(32.5) million | Higher loss by $155.7 million |
| Basic and diluted loss per share | $(902.19) | $(340.75) | More severe loss per share |
| Cash used in operating activities | $(72.0) million | $(30.1) million | Higher use by $41.9 million |
| Cash, cash equivalents and restricted cash | $20.5 million | $12.0 million | Up $8.4 million |
| Total debt, net of discount | $29.2 million | $1.1 million | Significant increase |
| Current liabilities | $70.6 million | $43.6 million | Up $27.0 million |
| Accumulated deficit | $247.1 million | $59.0 million | Increased materially |
Revenue Mix
- Cultivation solutions revenue declined 94% to $0.7 million, primarily due to migration toward a VFU leasing model.
- Agrify Insights revenue increased to $74 thousand from $8 thousand.
- Facility build-out revenue declined 36% to $23.1 million, reflecting completion of a construction project and $7.0 million of Bud & Mary’s revenue deferred because of litigation.
- Extraction solutions revenue increased 179% to $34.3 million, reflecting the acquired extraction businesses, including Lab Society, Precision, Cascade, and PurePressure.
Material Changes Versus 2021
- Cost of goods sold increased 65% to $90.1 million, driven primarily by inventory reserves and obsolescence, particularly amid weaker VFU demand.
- Inventory reserves increased to $32.4 million from $0.9 million.
- General and administrative expense increased 138% to $73.4 million, including approximately $33.1 million of increased trade and loan receivable allowances and higher employee and severance costs.
- A $69.9 million non-cash impairment charge eliminated all goodwill and intangible assets, following a decline in market capitalization, weaker sales, higher operating expenses, and deterioration in the cannabis operating environment.
- The company recorded a $2.9 million impairment of property and equipment.
- A $51.5 million non-cash gain resulted from changes in the fair value of liability-classified warrants.
- A $39.0 million loss on extinguishment of notes payable resulted primarily from the 2022 restructuring of the SPA Note and related warrant and issuance costs.
- The company acquired Lab Society on February 1, 2022 for approximately $8.0 million of estimated consideration, including cash, common stock, and contingent consideration. Lab Society contributed $4.5 million of revenue from acquisition through year-end.
Liquidity, Debt, and Cash Flow
Agrify reported substantial doubt about its ability to continue as a going concern. The company has recurring operating losses, negative operating cash flow, a working-capital deficiency, and an accumulated deficit of approximately $247.1 million. Management stated that continued operations depend on obtaining additional debt or equity financing and achieving sufficient operating cash flow.
- Cash and cash equivalents were $10.5 million at December 31, 2022. An additional $10.0 million was restricted as collateral for the senior secured Exchange Note.
- The Exchange Note had approximately $32.0 million of principal outstanding at year-end, before a $3.4 million unamortized debt discount. It bears interest at 9% and includes restrictive covenants, cash requirements, financing cash sweeps, and default provisions.
- Total future principal payments for debt were stated as $32.7 million, including $32.2 million due in 2023.
- Operating cash use increased to $72.0 million, primarily due to inventory purchases, TTK construction and equipment commitments, employee expenditures, and other working-capital needs.
- Financing activities generated $72.8 million, including debt and warrant proceeds, private-placement proceeds, ATM proceeds, and a public offering, partially offset by debt repayments.
- The company sold 306,628 shares through its ATM program during 2022 for $15.6 million of gross proceeds and approximately $15.0 million of net proceeds. The ATM program was discontinued on April 1, 2023 after total gross proceeds of $17.2 million.
- The company raised approximately $8.2 million of net proceeds in a December 2022 public offering that included common stock, pre-funded warrants, and warrants.
Guidance, Outlook, Risks, and Unusual Items
- Management does not intend to enter into new Total Turn-Key Solution arrangements for the foreseeable future, although existing customer commitments remain. These arrangements require substantial upfront capital and expose the company to customer credit, construction, production, and market risks.
- The company established approximately $14.7 million of reserves for the Bud & Mary’s TTK receivable and approximately $12.5 million for Greenstone-related balances. Net loans receivable were $12.2 million after a $33.1 million allowance.
- Bud & Mary’s sued Agrify over alleged unfair trade practices, breach of contract, and conversion. Agrify disputed the claims and reserved the outstanding balance. A separate Bowdoin Construction lawsuit alleged approximately $7.0 million of unpaid construction obligations and related claims.
- The company faced significant customer concentration: two customers represented approximately 28.8% of 2022 revenue, or $16.8 million.
- Agrify depends on cannabis customers operating under state-level licensing regimes while cannabis remains illegal under U.S. federal law. Changes in enforcement, banking access, licensing, taxation, or state legalization could materially affect demand.
- The company disclosed material weaknesses in internal control over financial reporting relating to timely close procedures, technical accounting expertise, segregation of duties, and accounting for complex financial instruments. Management concluded that internal controls were ineffective as of December 31, 2022.
- Accounting errors in previously issued warrant accounting required restatement of interim 2022 financial statements and contributed to delayed SEC filings.
- Agrify received Nasdaq notices concerning late filings and later received a Staff Delisting Determination. The company requested a hearing and disclosed that continued listing was not assured. It separately regained compliance with the minimum bid-price requirement in July 2023.
- Chief Financial Officer Timothy Oakes resigned effective February 28, 2023. Chief Executive Officer Raymond Chang assumed the principal financial and accounting officer role.
- Subsequent events included debt exchanges, additional equity issuance, related-party financing, the purchase of the company’s notes by an entity controlled by Mr. Chang, a Mack Molding settlement, and the issuance or repricing of substantial warrants.
- No cash dividends are expected in the foreseeable future.
Investor Verification Priorities
- Verify the issuer identity: the supplied document is Agrify Corporation, ticker AGFY, not RYTHM, Inc.
- Verify the company’s ability to continue as a going concern, including available unrestricted cash, financing capacity, debt maturities, and compliance with debt covenants.
- Review the $33.1 million allowance for loans receivable, including the Bud & Mary’s litigation reserve and Greenstone-related exposure.
- Assess whether inventory reserves are sufficient given the decline in VFU demand and the company’s obligations to Mack Molding.
- Review the full dilution impact of outstanding warrants, equity awards, subsequent warrant issuances, and related-party financings.
- Confirm the status of Nasdaq listing compliance and all delayed or restated SEC filings.
- Evaluate remediation of the disclosed material weaknesses and whether additional restatements or delayed filings remain possible.
- Reconcile the reported debt balances and subsequent 2023 debt exchanges with the company’s current capital structure.
- Assess customer concentration, the conversion of backlog and qualified pipeline into revenue, and the sustainability of extraction-solution growth.